Zinc Supplementation Associated With a Decrease in Mortality in COVID-19 Patients: A Meta-Analysis - PubMed

3 min read Original article ↗

Review

. 2023 Jun 10;15(6):e40231.

doi: 10.7759/cureus.40231. eCollection 2023 Jun.

Affiliations

Review

Zinc Supplementation Associated With a Decrease in Mortality in COVID-19 Patients: A Meta-Analysis

Spencer Z Rheingold et al. Cureus. .

Abstract

The COVID-19 pandemic has had a significant impact on the world, resulting in millions of deaths worldwide and imposing economic, political, and social problems. The use of nutritional supplementation for the prevention and mitigation of COVID-19 remains controversial. This meta-analysis aims to investigate the association between zinc supplementation, mortality, and symptomatology, among COVID-19-infected patients. A meta-analysis was conducted to compare the outcomes of mortality and symptomology of patients with COVID-19 receiving zinc supplementation and those not receiving zinc supplementation. PubMed/Medline, Cochrane, Web of Science, and CINAHL Complete were independently searched with the search terms "zinc" AND "covid" OR "sars-cov-2" "COVID-19" OR "coronavirus". After duplicates were removed, 1215 articles were identified. Five of these studies were used to assess mortality outcomes, and two were used to assess symptomatology outcomes. The meta-analysis was conducted through R 4.2.1 software (R Foundation, Vienna, Austria). Heterogeneity was evaluated by calculating the I2 index. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used. It was found that COVID-19-infected individuals treated with zinc supplements had a reduced risk of mortality compared with individuals not treated with a zinc supplement RR=0.63 (95%CI;0.52,0.77), p=0.005. For symptomology, it was found that COVID-19-infected individuals treated with zinc had no difference in symptomology than individuals not treated with a zinc supplement RR=0.52 (95%CI;0.00,24315.42), p=0.578. This data indicates that zinc supplementation is associated with decreased mortality in those with COVID-19 but does not change symptomatology. This is promising as zinc is widely available and may be valuable as a cost-effective way to prevent poor outcomes for those with COVID-19.

Keywords: coronavirus; covid; covid 19; covid 19 mortality; covid and zinc; sars cov 2; sars-cov-2; supplementation; zinc; zinc supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

References

    1. WHO coronavirus (COVID-19) dashboard. [ Aug; 2022 ]. 2022. https://covid19.who.int/ https://covid19.who.int/
    1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Zhou F, Yu T, Du R, et al. Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Zinc supplementation associated with a decrease in mortality in COVID-19 patients: a meta-analysis. Wang D, Hu B, Hu C, et al. JAMA. 2020;323:1061–1069. - PubMed
    1. Analysis of the predictive factors for a critical illness of COVID-19 during treatment－relationship between serum zinc level and critical illness of COVID-19. Yasui Y, Yasui H, Suzuki K, et al. Int J Infect Dis. 2020;100:230–236. - PMC - PubMed
    1. Zinc in infection and inflammation. Gammoh NZ, Rink L. Nutrients. 2017;9:624. - PMC - PubMed

Publication types

LinkOut - more resources